Browse by Author
Up a levelGroup by: Item Type | No Grouping
Number of items: 3.
Article
Zhao, Sizheng Steven 
ORCID: https://orcid.org/0000-0002-3558-7353
Harrison, Stephanie R
Thompson, Ben
Yates, Max
Eddison, Joe
Chan, Antoni
Clarke, Nick
et al.
ORCID: https://orcid.org/0000-0002-3558-7353
Harrison, Stephanie R
Thompson, Ben
Yates, Max
Eddison, Joe
Chan, Antoni
Clarke, Nick
et al.
Zhao, Sizheng Steven ORCID: https://orcid.org/0000-0002-3558-7353, Harrison, Stephanie R, Thompson, Ben, Yates, Max, Eddison, Joe, Chan, Antoni, Clarke, Nick, Corp, Nadia, Davis, Charlotte, Felix, Lambert, Flora, Kalveer, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Jones, Gareth T ORCID: https://orcid.org/0000-0003-0016-7591, Lamb, Christopher A, Marzo-Ortega, Helena ORCID: https://orcid.org/0000-0002-9683-3407, Murphy, Daniel J, Petrushkin, Harry, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan ORCID: https://orcid.org/0000-0002-1802-7311, Van Der Windt, Danielle A, Webb, Dale, Yiu, Zenas Z N and Gaffney, Karl ORCID: https://orcid.org/0000-0002-7863-9176
(2025)
The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.
Rheumatology, 64 (6).
pp. 3242-3254.
ISSN 1462-0324
ORCID: https://orcid.org/0000-0002-3558-7353, Harrison, Stephanie R, Thompson, Ben, Yates, Max, Eddison, Joe, Chan, Antoni, Clarke, Nick, Corp, Nadia, Davis, Charlotte, Felix, Lambert, Flora, Kalveer, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Jones, Gareth T ORCID: https://orcid.org/0000-0003-0016-7591, Lamb, Christopher A, Marzo-Ortega, Helena ORCID: https://orcid.org/0000-0002-9683-3407, Murphy, Daniel J, Petrushkin, Harry, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan ORCID: https://orcid.org/0000-0002-1802-7311, Van Der Windt, Danielle A, Webb, Dale, Yiu, Zenas Z N and Gaffney, Karl ORCID: https://orcid.org/0000-0002-7863-9176
Zhao, Sizheng Steven ORCID: https://orcid.org/0000-0002-3558-7353
Harrison, Stephanie R
Thompson, Ben
Yates, Max
Eddison, Joe
Chan, Antoni
Clarke, Nick
et al.
ORCID: https://orcid.org/0000-0002-3558-7353
Harrison, Stephanie R
Thompson, Ben
Yates, Max
Eddison, Joe
Chan, Antoni
Clarke, Nick
et al.
Zhao, Sizheng Steven ORCID: https://orcid.org/0000-0002-3558-7353, Harrison, Stephanie R, Thompson, Ben, Yates, Max, Eddison, Joe, Chan, Antoni, Clarke, Nick, Corp, Nadia, Davis, Charlotte, Felix, Lambert, Flora, Kalveer, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Jones, Gareth T ORCID: https://orcid.org/0000-0003-0016-7591, Lamb, Christopher A, Marzo-Ortega, Helena ORCID: https://orcid.org/0000-0002-9683-3407, Murphy, Daniel J, Petrushkin, Harry, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan ORCID: https://orcid.org/0000-0002-1802-7311, Van Der Windt, Danielle A, Webb, Dale, Yiu, Zenas Z N and Gaffney, Karl ORCID: https://orcid.org/0000-0002-7863-9176
(2025)
Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.
Rheumatology, 64 (6).
pp. 3234-3241.
ISSN 1462-0324
ORCID: https://orcid.org/0000-0002-3558-7353, Harrison, Stephanie R, Thompson, Ben, Yates, Max, Eddison, Joe, Chan, Antoni, Clarke, Nick, Corp, Nadia, Davis, Charlotte, Felix, Lambert, Flora, Kalveer, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Jones, Gareth T ORCID: https://orcid.org/0000-0003-0016-7591, Lamb, Christopher A, Marzo-Ortega, Helena ORCID: https://orcid.org/0000-0002-9683-3407, Murphy, Daniel J, Petrushkin, Harry, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan ORCID: https://orcid.org/0000-0002-1802-7311, Van Der Windt, Danielle A, Webb, Dale, Yiu, Zenas Z N and Gaffney, Karl ORCID: https://orcid.org/0000-0002-7863-9176
Prior, Yeliz ORCID: https://orcid.org/0000-0001-9831-6254
Battista, Simone ORCID: https://orcid.org/0000-0002-7471-1951
Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806
Bisset, Patricia
Derham, Sandra ORCID: https://orcid.org/0000-0003-4163-5697
Dockrell, Dervil M ORCID: https://orcid.org/0000-0003-4656-6205
Livesey, Caroline ORCID: https://orcid.org/0009-0006-8658-2065
et al.
ORCID: https://orcid.org/0000-0001-9831-6254
Battista, Simone ORCID: https://orcid.org/0000-0002-7471-1951
Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806
Bisset, Patricia
Derham, Sandra ORCID: https://orcid.org/0000-0003-4163-5697
Dockrell, Dervil M ORCID: https://orcid.org/0000-0003-4656-6205
Livesey, Caroline ORCID: https://orcid.org/0009-0006-8658-2065
et al.
Prior, Yeliz ORCID: https://orcid.org/0000-0001-9831-6254, Battista, Simone ORCID: https://orcid.org/0000-0002-7471-1951, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Bisset, Patricia, Derham, Sandra ORCID: https://orcid.org/0000-0003-4163-5697, Dockrell, Dervil M ORCID: https://orcid.org/0000-0003-4656-6205, Livesey, Caroline ORCID: https://orcid.org/0009-0006-8658-2065 and O’Callaghan, Gemma ORCID: https://orcid.org/0009-0003-9837-2450
(2025)
A scoping survey for the UK rheumatology occupational therapy capabilities framework.
Rheumatology Advances in Practice, 9 (3).
ISSN 2514-1775
ORCID: https://orcid.org/0000-0001-9831-6254, Battista, Simone ORCID: https://orcid.org/0000-0002-7471-1951, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Bisset, Patricia, Derham, Sandra ORCID: https://orcid.org/0000-0003-4163-5697, Dockrell, Dervil M ORCID: https://orcid.org/0000-0003-4656-6205, Livesey, Caroline ORCID: https://orcid.org/0009-0006-8658-2065 and O’Callaghan, Gemma ORCID: https://orcid.org/0009-0003-9837-2450